News Sentiment

XENE sentiment intelligence

Xenon Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 68.92 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+13.1% over one week, +32.3% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Xenon Pharmaceuticals (XENE) Could Be 14% Undervalued If Its Epilepsy Narrative Holds

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 13.1% Price confirming higher
Trend fit Trend active 32.3% over four weeks
Fair value 67.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 19
Neutral 36
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
Stock Titan 7
TradingView 6
TradingKey 4
simplywall.st 4
Stock Traders Daily 2
Investing.com 2
Finviz 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 21
Balance sheet 3
Analyst action 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56